Dr. Theresa Deisher
Theresa Deisher, PhD, is the president and founder of Sound Choice Pharmaceutical Institute, a donor funded nonprofit biomedical research organization and AVM Biotechnology. SCPI is doing studies to demonstrate the dangers of aborted fetal cell vaccines including their link to autism; and working to develop safer, more ethical alternatives. Click here to read Dr. Deisher's Curriculum Vitae.
Dr. Deisher speaks in opposition to SB277 at the California State Capitol on June 9, 2015 and talks about her 14 year old son, Henry, who passed away less than one month later.
Theresa Deisher, Ph.D. is a pioneer in the area of adult stem cell research. She discovered and identified adult heart stem cells and she continues her research looking for new breakthroughs. Dr. Deisher testifies at the MN House about vaccine safety. She presents research demonstrating a link between the rise in the rates of autism and the use of aborted fetal cells in the production of vaccines.
Dr. Theresa Deisher is interviewed on EWTN radio by "The Good Fight's", Barbara McGuigan. Recorded in April 2015, Dr. Deisher discusses aborted fetal cell vaccines and their consequences.
|
Dr. Deisher's Presentation at the 2015 Sound Choice Annual Event Dr. Deisher discusses the current worldwide autism epidemic; the temporal association between the use of human fetal cell lines for vaccine manufacture and autism disorder; the science of auto-immunity and insertional mutagenesis that can be triggered by human fetal manufactured vaccines; and clinical and real-life experiments demonstrating the risks of childhood vaccines containing extremely high levels of human fetal DNA and retroviral fragment contaminants.
Dr. Deisher is interviewed by Robert Scott Bell prior to the 2012 Autism One Conference. They discuss the toxic and genetic "poisons" contaminating vaccines and contributing to the increase of autism in children.
Click here for an interview with Dr. Theresa Deisher as she discusses medical ethics and the harvesting of aborted fetuses. (August, 2015) |
Learn more about Dr. Deisher's work at Sound Choice Pharmaceutical Institute and AVM Biotechnology.